Stock listing

COAG Stock Price, News, Filings & Events — Hemab Therapeutics Holdings, Inc.

Selected listing: COAG · BOATS · USD · US

This page tracks Hemab Therapeutics Holdings, Inc.'s COAG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COAG:BOATS. COAG:BOATS is the stock-level entry point for investors researching Hemab Therapeutics Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hemab Therapeutics Holdings, Inc. is a public company traded under the ticker COAG in the American market. The company has a market capitalization of approximately $2.3 billion. Hemab focuses on developing innovative therapies for patients with rare diseases.

COAG:BOATSUSDUSUpdated September 12, 2026
Hemab Therapeutics Holdings, Inc. logo
Ticker
COAG:BOATS
Asset type
Stock
Market cap
$1.84B
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Hemab Therapeutics Holdings, Inc. COAG:BOATS stock context

This page tracks Hemab Therapeutics Holdings, Inc.'s COAG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COAG:BOATS. COAG:BOATS is the stock-level entry point for investors researching Hemab Therapeutics Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hemab Therapeutics Holdings, Inc. is a public company traded under the ticker COAG in the American market. The company has a market capitalization of approximately $2.3 billion. Hemab focuses on developing innovative therapies for patients with rare diseases.

Latest news from Hemab Therapeutics Holdings, Inc.

All Hemab Therapeutics Holdings, Inc. news →

Research Hemab Therapeutics Holdings, Inc.

Alternate listings